Wealthquest Corp Acquires New Holdings in ZimVie Inc. (NASDAQ:ZIMV)

Key Points

• Wealthquest Corp has acquired 16,874 shares of ZimVie Inc., valued at approximately $182,000, during the first quarter, holding about 0.06% of the company's stock.
• Analysts have mixed ratings on ZimVie, with B. Riley downgrading the stock from "buy" to "neutral" and setting a price target of $19.00, while Barclays upgraded it to "equal weight" with a revised price objective of $19.00 as well.
• ZimVie shares are currently trading at $18.79, showing a 12-month low of $8.15 and a high of $21.53, amidst a market capitalization of $523.30 million.

Wealthquest Corp bought a new stake in ZimVie Inc. (NASDAQ:ZIMV - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 16,874 shares of the company's stock, valued at approximately $182,000. Wealthquest Corp owned about 0.06% of ZimVie at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of ZIMV. Wealth Enhancement Advisory Services LLC increased its position in shares of ZimVie by 5.8% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 15,127 shares of the company's stock valued at $211,000 after acquiring an additional 836 shares during the last quarter. Wells Fargo & Company MN increased its position in shares of ZimVie by 17.8% during the fourth quarter. Wells Fargo & Company MN now owns 17,037 shares of the company's stock valued at $238,000 after acquiring an additional 2,569 shares during the last quarter. Integrated Quantitative Investments LLC acquired a new stake in shares of ZimVie during the fourth quarter valued at about $248,000. Deutsche Bank AG increased its position in shares of ZimVie by 61.7% during the fourth quarter. Deutsche Bank AG now owns 23,796 shares of the company's stock valued at $332,000 after acquiring an additional 9,084 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in shares of ZimVie by 8.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 24,571 shares of the company's stock valued at $343,000 after acquiring an additional 1,852 shares during the last quarter. Hedge funds and other institutional investors own 95.63% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. B. Riley cut shares of ZimVie from a "buy" rating to a "neutral" rating and set a $19.00 price target for the company. in a research report on Thursday. Needham & Company LLC reaffirmed a "hold" rating on shares of ZimVie in a research note on Wednesday, April 9th. Barclays raised ZimVie from an "underweight" rating to an "equal weight" rating and lifted their price objective for the company from $9.00 to $19.00 in a research note on Tuesday, July 22nd. Wall Street Zen cut ZimVie from a "strong-buy" rating to a "buy" rating in a research note on Friday, July 18th. Finally, UBS Group dropped their price objective on ZimVie from $16.00 to $10.00 and set a "neutral" rating for the company in a research note on Thursday, May 15th. Four research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $17.75.

ZimVie Trading Down 0.5%

Shares of NASDAQ ZIMV opened at $18.79 on Friday. ZimVie Inc. has a twelve month low of $8.15 and a twelve month high of $21.53. The company has a current ratio of 2.14, a quick ratio of 1.48 and a debt-to-equity ratio of 0.58. The stock has a fifty day simple moving average of $10.86 and a 200-day simple moving average of $11.25. The stock has a market capitalization of $523.30 million, a PE ratio of -26.84 and a beta of 2.07.

ZimVie (NASDAQ:ZIMV - Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $0.26 EPS for the quarter. ZimVie had a positive return on equity of 6.44% and a negative net margin of 4.39%. The firm had revenue of $116.66 million during the quarter, compared to analysts' expectations of $112.60 million. On average, equities analysts forecast that ZimVie Inc. will post 0.6 earnings per share for the current year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.